What is the purpose and procedure of the PPD (Purified Protein Derivative) 2-step process for tuberculosis screening?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Purpose and Procedure of the PPD Two-Step Process for Tuberculosis Screening

The two-step PPD testing process is specifically designed to detect the booster phenomenon in individuals with waned TB infection, preventing misinterpretation of boosted reactions as new infections during subsequent serial testing. 1

Purpose of Two-Step Testing

  • The two-step PPD testing method addresses the "booster effect" phenomenon, where individuals previously infected with TB may have a diminished ability to react to tuberculin that can be restored by an initial PPD test 1
  • Without two-step testing, a boosted reaction on subsequent testing might be misinterpreted as a new infection (conversion), leading to unnecessary contact investigations and preventive therapy 1
  • Two-step testing is particularly important for individuals who will undergo repeated tuberculin testing, such as healthcare workers in TB screening programs 1
  • The process establishes a reliable baseline for future comparison, especially in individuals who may have been infected with TB in the distant past 2

Procedure for Two-Step Testing

First Step:

  • Administer the initial PPD test using the Mantoux technique (0.1 mL of PPD containing 5 tuberculin units) intradermally on the forearm 2
  • Read the test result 48-72 hours after administration by measuring the induration (hardened area) in millimeters 2
  • Document the result as negative or positive based on risk-stratified cutoff values (≥5 mm for high-risk, ≥10 mm for moderate-risk, ≥15 mm for low-risk individuals) 2

Second Step (for those with negative initial results):

  • If the first test is negative, administer a second PPD test 1-3 weeks after the first test 1
  • Read the second test result 48-72 hours after administration using the same technique 2
  • The result of this second test is considered the true baseline for future comparisons 1

Interpretation of Results

  • If the first test is positive: The individual is considered to have TB infection and should be evaluated for active TB and considered for treatment of latent TB infection 2
  • If the first test is negative and the second test is positive: This indicates a boosted reaction from prior TB infection that had waned over time; the individual is classified as previously infected 1
  • If both tests are negative: The individual is considered uninfected; any future positive test would represent a true conversion suggesting new infection 1

Clinical Applications

  • Two-step testing should be performed on all newly employed healthcare workers who have an initial negative PPD test and no documented negative PPD test within the preceding 12 months 1
  • It is particularly important in settings where periodic TB screening is conducted, such as healthcare facilities, correctional institutions, and nursing homes 1
  • The process is valuable for establishing baseline TB status in populations with high rates of prior TB exposure or BCG vaccination 1, 2
  • Two-step testing helps reduce unnecessary investigations and preventive therapy that might result from misinterpreting boosted reactions 1

Special Considerations

  • The booster phenomenon is more common in older adults but can occur in any age group 1
  • Boosted reactions are particularly common in individuals previously vaccinated with BCG or exposed to nontuberculous mycobacteria 1
  • The boosting effect can occur years after the initial infection or BCG vaccination 1
  • Repeated tuberculin skin testing with PPD will not induce a positive reaction in individuals who have no cellular immunity to tuberculin antigens 1

Common Pitfalls and Caveats

  • Failure to implement two-step testing in appropriate populations can lead to misclassification of boosted reactions as new infections 1
  • Improper timing between the first and second test (should be 1-3 weeks) may affect the accuracy of detecting the booster phenomenon 1
  • Reading the test outside the recommended 48-72 hour window reduces accuracy of both steps 2
  • Measuring erythema (redness) instead of induration (hardened area) leads to incorrect interpretation 2
  • Relying on patient self-reading of results is unreliable and not recommended 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

PPD Screening for Tuberculosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.